Medicare Enrolled
Melissa Studebaker, ARNP-C
Nurse Practitioner - Adult Health · Melbourne, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Studebaker from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Studebaker?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Studebaker
Melissa Studebaker is a nurse practitioner - adult health in Melbourne, FL, with 17 years of NPI registration. Based on federal Medicare data, Studebaker performed 15,605 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Studebaker received a total of $13,705 from 69 pharmaceutical and/or device companies across 544 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Studebaker is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 0% volume in FL
$13,705 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Advanced Practice Registered Nurse | 2513912 | Clear | April 30, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗15,605
Medicare services
Top 0% in FL for nurse practitioner - adult health
Not available
Unique patients (not deduplicated)
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
15,000 | $1 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
196 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
78 | $84 | $224 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
56 | $10 | $105 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
49 | $40 | $304 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
47 | $84 | $686 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
46 | $51 | $180 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
41 | $9 | $93 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
23 | $43 | $270 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
22 | $20 | $90 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
16 | $18 | $156 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
16 | $1 | $7 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
15 | $1 | $19 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
96.8% high complexity
2.2% medium
0.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,705
Total received (2021-2024)
Avg $3,426/year across 4 years
Top 1% in FL for nurse practitioner - adult health
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
544
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,731
2023
$3,245
2022
$3,272
2021
$4,457
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$218
PFIZER INC.
$209
Merck Sharp & Dohme LLC
$194
Regeneron Healthcare Solutions, Inc.
$182
Incyte Corporation
$173
Adaptive Biotechnologies Corporation
$146
Astellas Pharma US Inc
$144
Janssen Biotech, Inc.
$117
Novartis Pharmaceuticals Corporation
$115
Eisai Inc.
$102
Takeda Pharmaceuticals U.S.A., Inc.
$94
SEAGEN INC.
$75
Gilead Sciences, Inc.
$74
E.R. Squibb & Sons, L.L.C.
$74
TAIHO ONCOLOGY, INC.
$70
Bayer Healthcare Pharmaceuticals Inc.
$70
SOBI, INC
$65
Mirati Therapeutics, Inc.
$54
Celgene Corporation
$50
Karyopharm Therapeutics Inc.
$44
Legend Biotech USA Inc.
$43
PUMA BIOTECHNOLOGY, INC.
$37
Lilly USA, LLC
$33
Deciphera Pharmaceuticals Inc.
$29
PharmaEssentia USA Corporation
$29
Genmab U.S., Inc.
$27
SERVIER PHARMACEUTICALS LLC
$25
ABBVIE INC.
$24
Stemline Therapeutics Inc.
$24
JAZZ PHARMACEUTICALS INC.
$24
BeiGene USA, Inc.
$24
Pharmacosmos Therapeutics Inc.
$23
Ipsen Biopharmaceuticals, Inc
$22
GENZYME CORPORATION
$21
GlaxoSmithKline, LLC.
$21
ARRAY BIOPHARMA INC
$21
Genentech USA, Inc.
$20
Aveo Pharmaceuticals, Inc.
$15
Top 3 companies account for 22.7% of 2024 payments
All-time payments by company (2021-2024) ›
Novartis Pharmaceuticals Corporation
$2,174
AstraZeneca Pharmaceuticals LP
$1,022
PFIZER INC.
$841
Merck Sharp & Dohme LLC
$680
Seagen Inc.
$594
Amgen Inc.
$555
Janssen Biotech, Inc.
$492
Incyte Corporation
$465
Astellas Pharma US Inc
$440
E.R. Squibb & Sons, L.L.C.
$365
Regeneron Healthcare Solutions, Inc.
$343
Daiichi Sankyo Inc.
$337
GENZYME CORPORATION
$311
Celgene Corporation
$306
Genentech USA, Inc.
$281
Takeda Pharmaceuticals U.S.A., Inc.
$272
Lilly USA, LLC
$265
Pharmacosmos Therapeutics Inc.
$238
Eisai Inc.
$228
BeiGene USA, Inc.
$212
JAZZ PHARMACEUTICALS INC.
$187
Merck Sharp & Dohme Corporation
$170
Boehringer Ingelheim Pharmaceuticals, Inc.
$169
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Adaptive Biotechnologies Corporation
$166
Bayer HealthCare Pharmaceuticals Inc.
$148
Gilead Sciences, Inc.
$126
Karyopharm Therapeutics Inc.
$122
TAIHO ONCOLOGY, INC.
$115
Bayer Healthcare Pharmaceuticals Inc.
$113
GlaxoSmithKline, LLC.
$111
ARRAY BIOPHARMA INC
$106
Puma Biotechnology, Inc.
$92
PUMA BIOTECHNOLOGY, INC.
$87
SOBI, INC
$84
Ipsen Biopharmaceuticals, Inc
$82
Pharmacyclics LLC, An AbbVie Company
$79
Deciphera Pharmaceuticals Inc.
$75
SEAGEN INC.
$75
Epizyme, Inc.,
$65
ABBVIE INC.
$64
Taiho Oncology, Inc.
$56
Mirati Therapeutics, Inc.
$54
SERVIER PHARMACEUTICALS LLC
$50
Stemline Therapeutics Inc.
$49
Pharmacyclics LLC, an AbbVie Company
$44
EMD Serono, Inc.
$43
G1 Therapeutics, Inc.
$43
Legend Biotech USA Inc.
$43
EISAI INC.
$42
GE HealthCare
$34
CTI BioPharma Corp.
$33
MorphoSys, US Inc.
$31
TerSera Therapeutics LLC
$30
PharmaEssentia USA Corporation
$29
Sobi, Inc
$28
AMAG Pharmaceuticals, Inc.
$28
Genmab U.S., Inc.
$27
Alnylam Pharmaceuticals Inc.
$26
Servier Pharmaceuticals LLC
$25
AVEO Pharmaceuticals, Inc.
$22
TG THERAPEUTICS, INC.
$20
Foundation Medicine, Inc.
$20
CSL Behring
$20
ADC Therapeutics America, Inc.
$19
Sumitomo Pharma America, Inc.
$19
Global Blood Therapeutics, Inc.
$18
Aveo Pharmaceuticals, Inc.
$15
Dova Pharmaceuticals
$14
Top 3 companies account for 29.5% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · Afstyla · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CALQUENCE · COSELA · CYRAMZA · Columvi · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Enhertu · Epkinly · FERAHEME · FOTIVDA · FOUNDATIONONE CDX · FRUZAQLA · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · Nubeqa · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · Padcev · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tecentriq · Tibsovo · Trodelvy · UKONIQ · VENCLEXTA · VERZENIO · Vonjo · Vyloy · XALATAN · XALKORI · XOSPATA · XPOVIO · XTANDI · Xospata · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Adult-health nurse practitioners in nearby ZIP areas
87
County median income
$75,817
Nearest hospital to ZIP centroid (approximate)
ORLANDO HEALTH MELBOURNE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Studebaker is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Studebaker experienced with iron infusion (injectafer)?
Based on Medicare claims data, Studebaker performed 15,000 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Studebaker receive payments from pharmaceutical companies?
Yes. Studebaker received a total of $13,705 from 69 companies across 544 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Studebaker's costs compare to other adult-health nurse practitioners in Melbourne?
Studebaker's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Studebaker) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Adult-Health Nurse Practitioners in Melbourne
Browse adult-health nurse practitioners in Melbourne ranked by procedure volume and transparency data.
Highest volume
Top Adult-Health Nurse Practitioners in FL
Adult-health nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Adult-Health Nurse Practitioners in FL
Which FL adult-health nurse practitioners receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology